Brattle Principal Dr. Loren Smith led a global team conducting economic and econometric analyses on a potential multi-billion dollar joint venture between two pharmaceutical manufacturers. Dr. Smith’s analysis supported the proposed transaction, finding relatively little competition between the merging parties’ products. The deal received clearance in multiple jurisdictions, including without second requests in the US.